Closed-Loop Insulin Delivery for Glycemic Control in Noncritical Care.
Lia BallyHood ThabitSara HartnellEveline AndereggenYue RuanMalgorzata E WilinskaMark L EvansMaria M WertliAnthony P CollChristoph StettlerRoman HovorkaPublished in: The New England journal of medicine (2018)
Among inpatients with type 2 diabetes receiving noncritical care, the use of an automated, closed-loop insulin-delivery system resulted in significantly better glycemic control than conventional subcutaneous insulin therapy, without a higher risk of hypoglycemia. (Funded by Diabetes UK and others; ClinicalTrials.gov number, NCT01774565 .).